Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...
The Lupus Foundation of America describes lupus as a chronic disease that attacks the immune system, the part of the body ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback